Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi


  • Natalie M. NiemiEmail author
  • Jeffrey P. MacKeigan
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_205


 DUSP24;  Styxl1

Historical Background

MK-STYX was first identified bioinformatically due to its homology with the dual specificity phosphatases (DUSPs), a family of enzymes known for their ability to dephosphorylate not only tyrosine residues but also serine and threonine residues (Wishart and Dixon 1998). Specifically, MK-STYX resembles a MAP kinase phosphatase (MKP), which contains a rhodenase or  Cdc25 homology (CH2) domain in its N-terminus, while containing a DUSP domain in its C-terminus. The name of the protein reflects this similarity, as MK-STYX was coined from the phrase MAP Kinase Phosphatase-like Serine Threonine T yrosine inter action domain (Wishart and Dixon 1998). The Ser/Thr/Tyr interaction (STYX) domain was so named based on the observation that, though this domain shares significant homology to a DUSP domain, it lacks a critical cysteine residue necessary for catalysis; the conservative substitution of a serine in place of this residue renders this enzyme...
This is a preview of subscription content, log in to check access.


  1. Begley MJ, Dixon JE. The structure and regulation of myotubularin phosphatases. Curr Opin Struct Biol. 2005;15:614–20.CrossRefPubMedGoogle Scholar
  2. Begley MJ, Taylor GS, Brock MA, Ghosh P, Woods VL, Dixon JE. Molecular basis for substrate recognition by MTMR2, a myotubularin family phosphoinositide phosphatase. Proc Natl Acad Sci U S A. 2006;103:927–32.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massague J. Genes that mediate breast cancer metastasis to the brain. Nature. 2009;459:1005–9.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A. 2000;97:4291–6.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Flint AJ, Tiganis T, Barford D, Tonks NK. Development of “substrate-trapping” mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci U S A. 1997;94(5):1680.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Guillon N, Tirode F, Boeva V, Zynovyev A, Barillot E, Delattre O. The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS One. 2009;4:e4932.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Hinton SD, Myers MP, Roggero VR, Allison LA, Tonks NK. The pseudophosphatase MK-STYX interacts with G3BP and decreases stress granule formation. Biochem J. 2010;427:349–57.PubMedPubMedCentralCrossRefGoogle Scholar
  8. MacKeigan JP, Murphy LO, Blenis J. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol. 2005;7:591–600.CrossRefPubMedGoogle Scholar
  9. Robinson FL, Niesman IR, Beiswenger KK, Dixon JE. Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a charcot-marie-tooth 4B2-like peripheral neuropathy in mice. Proc Natl Acad Sci U S A. 2008;105:4916–21.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Siligan C, Ban J, Bachmaier R, Spahn L, Kreppel M, Schaefer KL, Poremba C, Aryee DN, Kovar H. EWS-FLI1 target genes recovered from Ewing’s sarcoma chromatin. Oncogene. 2005;24:2512–24.CrossRefPubMedGoogle Scholar
  11. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol. 2008;10:1027–38.CrossRefPubMedGoogle Scholar
  12. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol. 2006;7:833–46.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Wishart MJ, Dixon JE. Gathering STYX: phosphatase-like form predicts functions for unique protein-interaction domains. Trends Biochem Sci. 1998;23:301–6.CrossRefPubMedGoogle Scholar
  14. Wishart MJ, Denu JM, Williams JA, Dixon JE. A single mutation converts a novel phosphotyrosine binding domain into a dual-specificity phosphatase. J Biol Chem. 1995;270:26782–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Van Andel Institute Graduate SchoolVan Andel Research InstituteGrand RapidsUSA
  2. 2.Center for Cancer Genomics and Quantitative BiologyVan Andel Research InstituteGrand RapidsUSA